Search
- Page Path
- HOME > Search
Brief Report
- The laboratory test procedure to confirm rotavirus vaccine infection in severe complex immunodeficiency patients
- Su-Jin Chae, Seung-Rye Cho, Wooyoung Choi, Myung-Guk Han, Deog-Yong Lee
- Osong Public Health Res Perspect. 2021;12(4):269-273. Published online August 13, 2021
- DOI: https://doi.org/10.24171/j.phrp.2021.0079
- 5,385 View
- 101 Download
-
Abstract
PDF - The rotavirus vaccine is a live vaccine, and there is a possibility of infection by the virus strain used in the vaccine. We investigated the process of determining whether an infection was caused by the vaccine strain in a severe complex immunodeficiency (SCID) patient with rotavirus infection. The patient was vaccinated with RotaTeq prior to being diagnosed with SCID. The testing process was conducted in the following order: confirming rotavirus infection, determining its genotype, and confirming the vaccine strain. Rotavirus infection was confirmed through enzyme immunoassay and VP6 gene detection. G1 and P[8] were identified by multiplex polymerase chain reaction for the genotype, and G3 was further identified using a single primer. By detecting the fingerprint gene (WC3) of RotaTeq, it was confirmed that the detected virus was the vaccine strain. Genotypes G1 and P[8] were identified, and the infection was suspected of having been caused by rotavirus G1P[8]. G1P[8] is the most commonly detected genotype worldwide and is not included in the recombinant strains used in vaccines. Therefore, the infection was confirmed to have been caused by the vaccine strain by analyzing the genetic relationship between VP4 and VP7. Rotavirus infection by the vaccine strain can be identified through genotyping and fingerprint gene detection. However, genetic linkage analysis will also help to identify vaccine strains.
Original Article
- Utilization of Laboratory Tests for Tuberculosis and Mycobacterial Disease in Korea
- Chang-Ki Kim, Sung Won Choi, Mi-Sun Park
- Osong Public Health Res Perspect. 2014;5(Suppl):S24-S29. Published online December 31, 2014
- DOI: https://doi.org/10.1016/j.phrp.2014.10.008
- 3,248 View
- 20 Download
- 2 Crossref
-
Abstract
PDF
- Objectives
In Korea, a large portion of tuberculosis (TB) patients are diagnosed and treated in private institutes. Laboratory tests are crucial for TB control. There are many possible problems using laboratory tests in the private sector. In this study, we aimed to investigate the characteristics and trends of utilizing laboratory tests for TB and mycobacterial diseases in the private sector by analyzing the National Health Insurance (NHI) database.
Methods
After selecting TB or other mycobacteria-related test items, we searched the number and cost of each item on the website of the Health Insurance Review and Assessment Service using the code of each test from 2007 to 2012.
Results
Our data revealed that the number and cost of tests drastically increased between 2007 and 2012. Culture and molecular tests primarily contributed to the tremendous increases. For each year, concentrated smearing and fluorochrome staining were more commonly used. The number of serologic tests for latent TB infection stagnated, despite the expansion of contact investigation.
Conclusion
The NHI data could be considerably useful for understanding the utilization trends of laboratory tests for TB and mycobacterial diseases in Korea. Our data showed that TB laboratory systems have recently improved. In this study, many issues were noticed. Therefore, solutions to these issues are required and the continued monitoring of NHI data regarding laboratory diagnosis. -
Citations
Citations to this article as recorded by
- Tuberculosis Surveillance and Monitoring under the National Public-Private Mix Tuberculosis Control Project in South Korea 2016–2017
Jinsoo Min, Hyung Woo Kim, Yousang Ko, Jee Youn Oh, Ji Young Kang, Joosun Lee, Young Joon Park, Sung-Soon Lee, Jae Seuk Park, Ju Sang Kim
Tuberculosis and Respiratory Diseases.2020; 83(3): 218. CrossRef - Is Tuberculosis Still the Number One Infectious Disease in Korea?
Hae-Wol Cho, Chaeshin Chu
Osong Public Health and Research Perspectives.2014; 5: S1. CrossRef
- Tuberculosis Surveillance and Monitoring under the National Public-Private Mix Tuberculosis Control Project in South Korea 2016–2017
First
Prev
